Search
Results: 8
The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury
Krasimira Aleksandrova, Christina Bamia, Dagmar Drogan, Pagona Lagiou, Antonia Trichopoulou, Mazda Jenab, Veronika Fedirko, Isabelle Romieu, H Bas Bueno-De-Mesquita, Tobias Pischon, Kostas Tsilidis, Kim Overvad, Anne Tjønneland, Marie-Christine Bouton-Ruault, Laure Dossus, Antoine Racine, Rudolf Kaaks, Tilman Kühn, Christos Tsironis, Eleni-Maria Papatesta, George Saitakis, Domenico Palli, Salvatore Panico, Sara Grioni, Rosario Tumino, Paolo Vineis, Petra H Peeters, Elisabete Weiderpass, Marko Lukic, Tonje Braaten, J Ramón Quirós, Leila Luján-Barroso, María-José Sánchez, Maria-Dolores Chilarque, Eva Ardanas, Miren Dorronsoro, Lena Maria Nilsson, Malin Sund, Peter Wallström, Bodil Ohlsson, Kathryn E Bradbury, Kay-Tee Khaw, Nick Wareham, Magdalena Stepien, Talita Duarte-Salles, Nada Assi, Neil Murphy, Marc J Gunter, Elio Riboli, Heiner Boeing, Dimitrios Trichopoulos
Nov 11, 2015
European Prospective Investigation into Cancer and Nutrition Biomarkers Coffee Liver Cancer Mediation Adult Aged Biomarkers Carcinoma Hepatocellular Case-Control Studies Coffee Cohort Studies Diet Europe Female Hepatitis Humans Incidence Liver Liver Neoplasms Male Middle Aged Prospective Studies Risk Factors Statistics as Topic
Cholangiocarcinoma presenting as hemobilia and recurrent iron-deficiency anemia
Saif S Ahmad, Faisal Tm Basheer, Saad F Idris, Radhakrishnan Hariraj, Rajarathnam Mathialagan, Andrew Douds
Jun 16, 2011
Profiling for primary-care presentation, investigation and referral for liver cancers
BACKGROUND AND AIM: The incidence of liver cancer across Europe is increasing. There is a lack of evidence within the current literature on the identification and investigation of liver cancer within primary care. We aimed to...
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Victoria Hamill, Will Gelson, Douglas MacDonald, Paul Richardson, Stephen D Ryder, Mark Aldersley, Stuart McPherson, Sumita Verma, Rohini Sharma, Sharon Hutchinson, Jennifer Benselin, Eleanor Barnes, Indra Neil Guha, William L Irving, Hamish Innes
Feb 20, 2023
Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma.
Silvano Fasolato, Mariagrazia Ruvoletto, Giorgia Nardo, Andrea Rasola, Marco Sciacovelli, Giacomo Zanus, Cristian Turato, Santina Quarta, Liliana Terrin, Gian Paolo Fadini, Giulio Ceolotto, Maria Guido, Umberto Cillo, Stefano Indraccolo, Paolo Bernardi, Patrizia Pontisso
Apr 24, 2021
Cell proliferation and escape from apoptosis are important pathological features of hepatocellular carcinoma (HCC), one of the tumors with the highest mortality rate worldwide. The aim of the study was to evaluate the expression...
Assessing the impact of COVID-19 on liver cancer management (CERO-19).
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean-Charles Nault, Gonzalo Sapisochin, Lorenza Rimassa, Bruno Sangro, Jordi Bruix, Marco Sanduzzi-Zamparelli, Wacław Hołówko, Mohamed El Kassas, Tudor Mocan, Mohamed Bouattour, Philippe Merle, Frederik JH Hoogwater, Saleh A Alqahtani, Helen L Reeves, David J Pinato, Emmanouil Giorgakis, Tim Meyer, Gerda Elisabeth Villadsen, Henning Wege, Massimiliano Salati, Beatriz Mínguez, Giovan Giuseppe Di Costanzo, Christoph Roderburg, Frank Tacke, María Varela, Peter R Galle, Mario Reis Alvares-da-Silva, Jörg Trojan, John Bridgewater, Giuseppe Cabibbo, Christian Toso, Anja Lachenmayer, Andrea Casadei-Gardini, Hidenori Toyoda, Tom Lüdde, Rosanna Villani, Ana María Matilla Peña, Cassia Regina Guedes Leal, Monica Ronzoni, Manuel Delgado, Christie Perelló, Sonia Pascual, José Luis Lledó, Josepmaria Argemi, Bristi Basu, Leonardo da Fonseca, Juan Acevedo, Alexander R Siebenhüner, Chiara Braconi, Brandon M Meyers, Alessandro Granito, Margarita Sala, Carlos Rodríguez-Lope, Lorraine Blaise, Manuel Romero-Gómez, Federico Piñero, Dhanny Gomez, Vivianne Mello, Rogerio Camargo Pinheiro Alves, Alex França, Fernanda Branco, Giovanni Brandi, Gustavo Pereira, Susanna Coll, Maria Guarino, Carlos Benítez, Maria Margarita Anders, Juan C Bandi, Mercedes Vergara, Mariona Calvo, Markus Peck-Radosavljevic, Ignacio García-Juárez, Vincenzo Cardinale, Mar Lozano, Martina Gambato, Stefano Okolicsanyi, Dalia Morales-Arraez, Alessandra Elvevi, Alberto E Muñoz, Alberto Lué, Massimo Iavarone, Maria Reig
Sep 02, 2021
BACKGROUND & AIMS: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the...
BCLC Barcelona Clinic Liver Cancer CERO-19 Liver Cancer Outcome in the COVID-19-pandemic Project covid-19 covid-19 Coronavirus disease 2019 Cholangiocarcinoma Clinical Trials ENS-CCA European Network for the Study of Cholangiocarcinoma HCC hepatocellular carcinoma hepatocellular carcinoma LC liver cancer LT liver transplantation Liver Cancer Management Nurses SARS-CoV-2 severe acute respiratory syndrome coronavirus-2 iCCA intrahepatic cholangiocarcinoma
Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.
David J Hughes, Talita Duarte-Salles, Sandra Hybsier, Antonia Trichopoulou, Magdalena Stepien, Krasimira Aleksandrova, Kim Overvad, Anne Tjønneland, Anja Olsen, Aurélie Affret, Guy Fagherazzi, Marie-Christine Boutron-Ruault, Verena Katzke, Rudolf Kaaks, Heiner Boeing, Christina Bamia, Pagona Lagiou, Eleni Peppa, Domenico Palli, Vittorio Krogh, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote, Hendrik Bastiaan Bueno-de-Mesquita, Petra H Peeters, Dagrun Engeset, Elisabete Weiderpass, Cristina Lasheras, Antonio Agudo, Maria-José Sánchez, Carmen Navarro, Eva Ardanaz, Miren Dorronsoro, Oskar Hemmingsson, Nicholas J Wareham, Kay-Tee Khaw, Kathryn E Bradbury, Amanda J Cross, Marc Gunter, Elio Riboli, Isabelle Romieu, Lutz Schomburg, Mazda Jenab
Sep 20, 2016
hepatobiliary cancer hepatocellular carcinoma Liver Cancer prospective cohort selenium selenium status selenoprotein P Aged Bile Ducts Biliary Tract Neoplasms Carcinoma Hepatocellular Case-Control Studies Deficiency Diseases Europe Female Gallbladder Humans Liver Liver Neoplasms Logistic Models Male Middle Aged Nutritional Status Odds Ratio Prospective Studies Risk Factors selenium Selenoprotein P
Dynamics in Circulating Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC – A Substudy From the SORAMIC Trial
Introduction Prediction of response to treatment in patients with advanced hepatocellular carcinoma (HCC) may assist in the selection of personalized...
Kerstin Schütte, Juozas Kupčinskas, Egidijus Morkunas, Osman Öcal, Regina Schinner, Max Seidensticker, Enrico N de Toni, Najib Ben Khaled, Maciej Pech, Daniel Palmer, Thomas Berg, Christian Sengel, Bristi Basu, Juan W Valle, Julia Benckert, Antonio Gasbarrini, Bruno Sangro, Peter Malfertheiner, Jens Ricke
Aug 25, 2022